CytoVale's Series B Round

CytoVale raised a round of funding on December 26, 2017. Investors include Breakout Ventures.

CytoVale is an early-stage medical diagnostics startup company based in South San Francisco, CA. Commercializing groundbreaking microfluidic technology developed by Prof. Dino Di Carlo at UCLA, CytoVa…

Articles about CytoVale's Series B Round: